This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tergaonkar, V.
Right arrow Articles by Verma, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tergaonkar, V.
Right arrow Articles by Verma, I. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2003, p. 8070-8083, Vol. 23, No. 22
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.22.8070-8083.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

I{kappa}B Kinase-Independent I{kappa}B{alpha} Degradation Pathway: Functional NF-{kappa}B Activity and Implications for Cancer Therapy

Vinay Tergaonkar, Virginie Bottero, Masahito Ikawa,{dagger} Qiutang Li, and Inder M. Verma*

Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037

Received 22 April 2003/ Returned for modification 7 July 2003/ Accepted 9 August 2003

Antiapoptotic activity of NF-{kappa}B in tumors contributes to acquisition of resistance to chemotherapy. Degradation of I{kappa}B is a seminal step in activation of NF-{kappa}B. The I{kappa}B kinases, IKK1 and IKK2, have been implicated in both I{kappa}B degradation and subsequent modifications of NF{kappa}B. Using mouse embryo fibroblasts (MEFs) devoid of both IKK1 and IKK2 genes (IKK1/2-/-), we document a novel I{kappa}B degradation mechanism. We show that this degradation induced by a chemotherapeutic agent, doxorubicin (DoxR), does not require the classical serine 32 and 36 phosphorylation or the PEST domain of I{kappa}B{alpha}. Degradation of I{kappa}B{alpha} is partially blocked by phosphatidylinositol 3-kinase inhibitor LY294002 and is mediated by the proteasome. Free NF-{kappa}B generated by DoxR-induced I{kappa}B degradation in IKK1/2-/- cells is able to activate chromatin based NF-{kappa}B reporter gene and expression of the endogenous target gene, I{kappa}B{alpha}. These results also imply that modification of NF-{kappa}B by IKK1 or IKK2 either prior or subsequent to its release from I{kappa}B is not essential for NF-{kappa}B-mediated gene expression at least in response to DNA damage. In addition, DoxR-induced cell death in IKK1/2-/- MEFs is enhanced by simultaneous inhibition of NF-{kappa}B activation by blocking the proteasome activity. These results reveal an additional pathway of activating NF-{kappa}B during the course of anticancer therapy and provide a mechanistic basis for the observation that proteasome inhibitors could be used as adjuvants in chemotherapy.


* Corresponding author. Mailing address: Laboratory of Genetics, The Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 453-4100. Fax: (858) 558-7454. E-mail: verma{at}salk.edu.

{dagger} Present address: Genome Information Research Center, Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, Japan.


Molecular and Cellular Biology, November 2003, p. 8070-8083, Vol. 23, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.22.8070-8083.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bednarski, B. K., Ding, X., Coombe, K., Baldwin, A. S., Kim, H. J. (2008). Active roles for inhibitory {kappa}B kinases {alpha} and {beta} in nuclear factor-{kappa}B-mediated chemoresistance to doxorubicin. Molecular Cancer Therapeutics 7: 1827-1835 [Abstract] [Full Text]  
  • Khong, T., Sharkey, J., Spencer, A. (2008). The effect of azacitidine on interleukin-6 signaling and nuclear factor-{kappa}B activation and its in vitro and in vivo activity against multiple myeloma. haematol 93: 860-869 [Abstract] [Full Text]  
  • Biswas, G., Tang, W., Sondheimer, N., Guha, M., Bansal, S., Avadhani, N. G. (2008). A Distinctive Physiological Role for I{kappa}B{beta} in the Propagation of Mitochondrial Respiratory Stress Signaling. J. Biol. Chem. 283: 12586-12594 [Abstract] [Full Text]  
  • Huang, R. S., Duan, S., Kistner, E. O., Bleibel, W. K., Delaney, S. M., Fackenthal, D. L., Das, S., Dolan, M. E. (2008). Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity. Cancer Res. 68: 3161-3168 [Abstract] [Full Text]  
  • Greve, B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R. A., Coyle, A., Kuchroo, V. K., Rajewsky, K., Schmidt-Supprian, M. (2007). I{kappa}B Kinase 2/beta Deficiency Controls Expansion of Autoreactive T Cells and Suppresses Experimental Autoimmune Encephalomyelitis. J. Immunol. 179: 179-185 [Abstract] [Full Text]  
  • Izzo, J. G., Malhotra, U., Wu, T.-T., Luthra, R., Correa, A. M., Swisher, S. G., Hofstetter, W., Chao, K.S. C., Hung, M.-C., Ajani, J. A. (2007). Clinical Biology of Esophageal Adenocarcinoma after Surgery Is Influenced by Nuclear Factor-{kappa}B Expression. Cancer Epidemiol. Biomarkers Prev. 16: 1200-1205 [Abstract] [Full Text]  
  • Ahn, K. S., Sethi, G., Aggarwal, B. B. (2007). Simvastatin Potentiates TNF-{alpha}-Induced Apoptosis through the Down-Regulation of NF-{kappa}B-Dependent Antiapoptotic Gene Products: Role of I{kappa}B{alpha} Kinase and TGF-beta-Activated Kinase-1. J. Immunol. 178: 2507-2516 [Abstract] [Full Text]  
  • Morais, C., Pat, B., Gobe, G., Johnson, D. W., Healy, H. (2006). Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol Dial Transplant 21: 3377-3388 [Abstract] [Full Text]  
  • Park, S.-S., Kim, J.-M., Kim, D.-S., Kim, I.-H., Kim, S.-Y. (2006). Transglutaminase 2 Mediates Polymer Formation of I-{kappa}B{alpha} through C-terminal Glutamine Cluster. J. Biol. Chem. 281: 34965-34972 [Abstract] [Full Text]  
  • Horiguchi, K., Arai, S., Nishihara, T., Nishikawa, J.-i. (2006). AIB1 Promotes DNA Replication by JNK Repression and AKT Activation during Cellular Stress. J Biochem 140: 409-419 [Abstract] [Full Text]  
  • Dolcet, X., Llobet, D., Encinas, M., Pallares, J., Cabero, A., Schoenenberger, J. A., Comella, J. X., Matias-Guiu, X. (2006). Proteasome Inhibitors Induce Death but Activate NF-{kappa}B on Endometrial Carcinoma Cell Lines and Primary Culture Explants. J. Biol. Chem. 281: 22118-22130 [Abstract] [Full Text]  
  • Ralstin, M. C., Gage, E. A., Yip-Schneider, M. T., Klein, P. J., Wiebke, E. A., Schmidt, C. M. (2006). Parthenolide Cooperates with NS398 to Inhibit Growth of Human Hepatocellular Carcinoma Cells through Effects on Apoptosis and G0-G1 Cell Cycle Arrest. Mol Cancer Res 4: 387-399 [Abstract] [Full Text]  
  • Lu, H., Ouyang, W., Huang, C. (2006). Inflammation, a Key Event in Cancer Development. Mol Cancer Res 4: 221-233 [Abstract] [Full Text]  
  • Izzo, J. G., Malhotra, U., Wu, T.-T., Ensor, J., Luthra, R., Lee, J. H., Swisher, S. G., Liao, Z., Chao, K.S. C., Hittelman, W. N., Aggarwal, B. B., Ajani, J. A. (2006). Association of Activated Transcription Factor Nuclear Factor {kappa}B With Chemoradiation Resistance and Poor Outcome in Esophageal Carcinoma. JCO 24: 748-754 [Abstract] [Full Text]  
  • Li, Q., Lu, Q., Bottero, V., Estepa, G., Morrison, L., Mercurio, F., Verma, I. M. (2005). Enhanced NF-{kappa}B activation and cellular function in macrophages lacking I{kappa}B kinase 1 (IKK1). Proc. Natl. Acad. Sci. USA 102: 12425-12430 [Abstract] [Full Text]  
  • Newcomb, E. W., Ali, M. A., Schnee, T., Lan, L., Lukyanov, Y., Fowkes, M., Miller, D. C., Zagzag, D. (2005). Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1{alpha} expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy. Neuro Oncol Duke 7: 225-235 [Abstract]  
  • Massa, P. E., Li, X., Hanidu, A., Siamas, J., Pariali, M., Pareja, J., Savitt, A. G., Catron, K. M., Li, J., Marcu, K. B. (2005). Gene Expression Profiling in Conjunction with Physiological Rescues of IKK{alpha}-null Cells with Wild Type or Mutant IKK{alpha} Reveals Distinct Classes of IKK{alpha}/NF-{kappa}B-dependent Genes. J. Biol. Chem. 280: 14057-14069 [Abstract] [Full Text]  
  • Buss, H., Dorrie, A., Schmitz, M. L., Hoffmann, E., Resch, K., Kracht, M. (2004). Constitutive and Interleukin-1-inducible Phosphorylation of p65 NF-{kappa}B at Serine 536 Is Mediated by Multiple Protein Kinases Including I{kappa}B Kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF Family Member-associated (TANK)-binding Kinase 1 (TBK1), and an Unknown Kinase and Couples p65 to TATA-binding Protein-associated Factor II31-mediated Interleukin-8 Transcription. J. Biol. Chem. 279: 55633-55643 [Abstract] [Full Text]  
  • Hayden, M. S., Ghosh, S. (2004). Signaling to NF-{kappa}B. Genes Dev. 18: 2195-2224 [Abstract] [Full Text]  
  • Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., Iglehart, J. D. (2004). NF-{kappa}B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. USA 101: 10137-10142 [Abstract] [Full Text]  
  • Bohuslav, J., Chen, L.-f., Kwon, H., Mu, Y., Greene, W. C. (2004). p53 Induces NF-{kappa}B Activation by an I{kappa}B Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1. J. Biol. Chem. 279: 26115-26125 [Abstract] [Full Text]  
  • Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., Kuo, M.-L. (2004). Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation. J. Biol. Chem. 279: 24015-24023 [Abstract] [Full Text]  
  • Veiby, O. P., Read, M. A. (2004). Chemoresistance: Impact of Nuclear Factor (NF)-{kappa}B Inhibition by Small Interfering RNA: Commentary re J. Guo et al., Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-{kappa}B p65 Subunit. Clin Cancer Res 2004;10:3333-3341. Clin. Cancer Res. 10: 3262-3264 [Full Text]